These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8775832)

  • 1. Overview: medications development for the treatment of drug abuse.
    Vocci F; Chiang CN; Cummings L; Hawks R
    NIDA Res Monogr; 1995; 149():4-15. PubMed ID: 8775832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
    McCann DJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illicit use of clonidine in opiate-abusing pregnant women.
    Anderson F; Paluzzi P; Lee J; Huggins G; Svikis D
    Obstet Gynecol; 1997 Nov; 90(5):790-4. PubMed ID: 9351766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication development for addictive disorders: the state of the science.
    Vocci FJ; Acri J; Elkashef A
    Am J Psychiatry; 2005 Aug; 162(8):1432-40. PubMed ID: 16055764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Buprenorphine as opioid substitution to pregnant addicts].
    Rasmussen ET; Nielsen LB
    Ugeskr Laeger; 2003 Sep; 165(38):3607-8. PubMed ID: 14556390
    [No Abstract]   [Full Text] [Related]  

  • 11. Medications development: successes and challenges.
    Vocci F; Ling W
    Pharmacol Ther; 2005 Oct; 108(1):94-108. PubMed ID: 16083966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].
    Haro G; Cervera G; Martínez-Raga J; Pérez-Gálvez B; Fernández-Garcés M; Sanjuan J
    Actas Esp Psiquiatr; 2003; 31(4):205-19. PubMed ID: 12838444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New horizons for therapeutics in drug and alcohol abuse.
    Jupp B; Lawrence AJ
    Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy and drug dependence].
    Schneider C; Fischer G; Diamant K; Hauk R; Pezawas L; Lenzinger E; Kasper S
    Wien Klin Wochenschr; 1996; 108(19):611-4. PubMed ID: 9012146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction].
    Thirion X; Barrau K; Micallef J; Haramburu F; Lowenstein W; Sanmarco JL
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A10-7. PubMed ID: 10855372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications development at the National Institute on Drug Abuse: focus on cocaine.
    Johnson DN; Vocci FJ
    NIDA Res Monogr; 1993; 135():57-70. PubMed ID: 8289904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of narcotic dependence in pregnant women and the neonatal abstinence syndrome in newborn infants].
    Rabe-Jabłońska J
    Pol Tyg Lek; 1988 Nov; 43(45):1427-9. PubMed ID: 3253702
    [No Abstract]   [Full Text] [Related]  

  • 20. Research issues related to development of medications for treatment of cocaine addiction.
    Klein M
    Ann N Y Acad Sci; 1998 May; 844():75-91. PubMed ID: 9668666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.